by rss feed | Oct 13, 2026 | News Feeds
We are pleased to announce the appointment of Dr Adrijana Vinter as Chief Executive Officer. Dr Vinter brings more than 20 years of experience spanning medicinal chemistry research, commercial development and executive leadership in the pharmaceutical and contract...
by rss feed | Oct 13, 2026 | News Feeds
In a phase 1 study of 10 adults with advanced retinitis pigmentosa, researchers found that optogenetic gene therapy combined with light-stimulating goggles was generally well tolerated, although one participant experienced a severe but transient ocular adverse event....
by rss feed | Oct 13, 2026 | News Feeds
Diseases such as Alzheimer's and frontotemporal dementia are considered neurodegenerative tauopathies, in which tau proteins in the brain misfold and lead to cognitive decline. Read Original...
by rss feed | Oct 13, 2026 | News Feeds
The first Europe-wide expert working group on Artificial Intelligence in mental health launches today to the ECNP congress in Munich, where the group will host an open discussion, setting out the potential, the problems, and possible directions for AI in psychiatry...
by rss feed | Oct 13, 2026 | News Feeds
ADHD seems to be in the news everywhere, but is this due to a rise in cases or to changing awareness and diagnosis? Read Original...
by rss feed | Oct 13, 2026 | News Feeds
A new Cochrane review finds that existing evidence is too uncertain to determine whether medical cannabis improves sleep or daytime functioning in people with insomnia. Read Original...